JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Home・Elenco Azioni・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Chiusa

SettoreSettore sanitario

36.83 -1.84

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

36.62

Massimo

37.57

Metriche Chiave
By Trading Economics
Entrata	11M 51M
Vendite	39M 239M
P/E Media del settore	11.786 90.422
EPS	1.08
Margine di Profitto	21.242
Dipendenti	268
EBITDA	14M 73M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+17.1% upside

Dividendi
By Dow Jones
Utili prossimi	24 feb 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	464M 2.2B
Apertura precedente	38.67
Chiusura precedente	36.83

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

29.8 / N/A Supporto e resistenza

Harmony Biosciences Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

28 gen 2026, 23:51 UTC

Utili

Correction to Samsung Fourth-Quarter Net Profit Article

28 gen 2026, 23:49 UTC

Azioni calde

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 gen 2026, 23:19 UTC

Utili

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 gen 2026, 22:43 UTC

Utili

Waste Management Logs Higher 4Q Profit as Revenue Rises

28 gen 2026, 23:49 UTC

Discorsi di Mercato

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 gen 2026, 23:30 UTC

Discorsi di Mercato

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 gen 2026, 23:28 UTC

Utili

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 gen 2026, 23:26 UTC

Utili

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 gen 2026, 23:21 UTC

Utili

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 gen 2026, 23:18 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 gen 2026, 22:58 UTC

Utili

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 gen 2026, 22:48 UTC

Discorsi di Mercato

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 gen 2026, 22:45 UTC

Utili

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 gen 2026, 22:44 UTC

Utili

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 gen 2026, 22:43 UTC

Utili

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 gen 2026, 22:41 UTC

Utili

Azioni calde

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 gen 2026, 22:41 UTC

Discorsi di Mercato

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 gen 2026, 22:41 UTC

Utili

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 gen 2026, 22:40 UTC

Utili

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 gen 2026, 22:39 UTC

Utili

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 gen 2026, 22:38 UTC

Utili

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 gen 2026, 22:37 UTC

Utili

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 gen 2026, 22:35 UTC

Utili

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 gen 2026, 22:26 UTC

Discorsi di Mercato

Utili

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 gen 2026, 22:20 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

28 gen 2026, 22:20 UTC

Discorsi di Mercato

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

28 gen 2026, 22:17 UTC

Discorsi di Mercato

Utili

Meta Doubles Down on Personalization Despite Regulatory Concerns -- Market Talk

28 gen 2026, 22:09 UTC

Utili

Microsoft's Earnings Surge, Elevated by Cloud Business -- 2nd Update

28 gen 2026, 22:02 UTC

Utili

Waste Management Sees FY26 Rev $26.43B-$26.63B >WM

28 gen 2026, 22:01 UTC

Utili

Waste Management: Strong Growth in Earnings and Cash Flow From Ops Expected to Continue in 2026 >WM

Confronto tra pari

Modifica del prezzo

Harmony Biosciences Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

17.1% in crescita

Previsioni per 12 mesi

Media 43.75 USD 17.1%

Alto 55 USD

Basso 32 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Harmony Biosciences Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 5 che hanno fornito valutazioni azionarie a Harmony Biosciences Holdings Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

29.8 / N/ASupporto e resistenza

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.